This is a Validated Antibody Database (VAD) review about human ALCAM, based on 79 published articles (read how Labome selects the articles), using ALCAM antibody in all methods. It is aimed to help Labome visitors find the most suited ALCAM antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ALCAM synonym: CD166; MEMD

Santa Cruz Biotechnology
mouse monoclonal (B-6)
  • immunocytochemistry; human; loading ...; fig 1a
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz, sc-74558) was used in immunocytochemistry on human samples (fig 1a). Adipocyte (2019) ncbi
  • western blot; human; loading ...; fig 4f
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz, H-108) was used in western blot on human samples (fig 4f). Oncogenesis (2016) ncbi
  • western blot; human; loading ...; fig 3C
Santa Cruz Biotechnology ALCAM antibody (Santa cruz, H-108) was used in western blot on human samples (fig 3C). Mol Cell Biol (2015) ncbi
mouse monoclonal (H-9)
  • immunocytochemistry; human
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz Biotechnology, sc-74557) was used in immunocytochemistry on human samples . Cell Signal (2015) ncbi
  • western blot; human; 1:1000; loading ...; fig 6g
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz, H-108) was used in western blot on human samples at 1:1000 (fig 6g). Mol Cancer (2015) ncbi
  • immunocytochemistry; human; 1:100; tbl 1
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz, sc25624) was used in immunocytochemistry on human samples at 1:100 (tbl 1). Acta Biomater (2015) ncbi
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz Biotechnology, H-108) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 3a). Mol Biol Cell (2014) ncbi
mouse monoclonal (H-9)
  • western blot; human
Santa Cruz Biotechnology ALCAM antibody (Santa Cruz Biotechnology, SC-74557) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
R&D Systems
mouse monoclonal (105902)
  • flow cytometry; mouse; loading ...; fig s1a
R&D Systems ALCAM antibody (R&D Systems, 105902) was used in flow cytometry on mouse samples (fig s1a). EBioMedicine (2018) ncbi
domestic goat polyclonal
  • flow cytometry; mouse; loading ...; fig 4a
R&D Systems ALCAM antibody (R&D Systems, FAB1172P) was used in flow cytometry on mouse samples (fig 4a). Nat Med (2018) ncbi
domestic goat polyclonal
  • flow cytometry; mouse; 1:50; loading ...; fig s1g
R&D Systems ALCAM antibody (R&D, FAB1172P) was used in flow cytometry on mouse samples at 1:50 (fig s1g). Leukemia (2018) ncbi
domestic goat polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...; fig 1i
In order to understand the contribution of floor-plate-derived netrin-1 to commissural axon guidance, R&D Systems ALCAM antibody (R&D Systems, AF656) was used in immunohistochemistry on mouse samples at 1:500 (fig 1i). Nature (2017) ncbi
mouse monoclonal (105902)
  • flow cytometry; human; loading ...; fig 7d
R&D Systems ALCAM antibody (R&D Systems, FAB6561P) was used in flow cytometry on human samples (fig 7d). Stem Cell Reports (2016) ncbi
domestic goat polyclonal
  • flow cytometry; mouse; 1:25; loading ...; fig 1a
R&D Systems ALCAM antibody (R&D Systems, FAB1172P) was used in flow cytometry on mouse samples at 1:25 (fig 1a). Nat Commun (2016) ncbi
mouse monoclonal (105901)
  • blocking or activating experiments; human; loading ...; fig 5c
R&D Systems ALCAM antibody (R&D Systems, 105901) was used in blocking or activating experiments on human samples (fig 5c). Sci Rep (2016) ncbi
mouse monoclonal (105902)
  • flow cytometry; human; fig s1
R&D Systems ALCAM antibody (R&D, FAB6561P) was used in flow cytometry on human samples (fig s1). Nat Commun (2016) ncbi
mouse monoclonal (105902)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, R&D Systems ALCAM antibody (R&D Systems, FAB6561P) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
Bio-Rad
mouse monoclonal (3A6)
  • flow cytometry; human; 1:50; fig 3a, 3b
Bio-Rad ALCAM antibody (ABD Serotec, MCA1926A488T) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; 1:20; fig 2a
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, Bio-Rad ALCAM antibody (AbD Serotec, MCA1926A488) was used in flow cytometry on human samples at 1:20 (fig 2a). Nat Commun (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig 2
Bio-Rad ALCAM antibody (AbD Serotec, MCA1926F) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; 1:50
Bio-Rad ALCAM antibody (AbD Serotec, MCA1926F) was used in flow cytometry on human samples at 1:50. Int J Mol Med (2012) ncbi
Abcam
  • immunocytochemistry; domestic sheep; fig 4
Abcam ALCAM antibody (abcam, ab78649) was used in immunocytochemistry on domestic sheep samples (fig 4). Cell Tissue Bank (2016) ncbi
domestic rabbit monoclonal (EPR2759(2))
  • western blot; human; fig 1
Abcam ALCAM antibody (Epitomics, 3133) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EPR2759(2))
  • immunohistochemistry; human
  • western blot; human
Abcam ALCAM antibody (Epitomics, 3133) was used in immunohistochemistry on human samples and in western blot on human samples . Cell Signal (2015) ncbi
domestic rabbit monoclonal (EPR2759(2))
  • western blot; human; loading ...; fig 4c
Abcam ALCAM antibody (Abcam, ab109215) was used in western blot on human samples (fig 4c). Mol Carcinog (2015) ncbi
domestic rabbit monoclonal (EPR2759(2))
  • western blot; human
Abcam ALCAM antibody (Epitomics, 3133) was used in western blot on human samples . Biochem Biophys Res Commun (2014) ncbi
Invitrogen
mouse monoclonal (3A6)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen ALCAM antibody (eBioscience, 12-1668) was used in flow cytometry on mouse samples (fig 3d). Cell Rep (2018) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of galectin-3 in gastrointestinal cancer stem cells, Invitrogen ALCAM antibody (BD, 46166842) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; loading ...; fig 4
Invitrogen ALCAM antibody (eBioscience, 3A6) was used in flow cytometry on human samples (fig 4). Sci Rep (2016) ncbi
BioLegend
mouse monoclonal (3A6)
  • flow cytometry; human; 1:80; loading ...; fig 10
In order to identify human cytomegalovirus genes within the US12 family containing novel natural killer cell evasion functions, BioLegend ALCAM antibody (Biolegend, 343904) was used in flow cytometry on human samples at 1:80 (fig 10). elife (2017) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig 4a
  • immunocytochemistry; human; fig 4g
BioLegend ALCAM antibody (BioLegend, 3A6) was used in flow cytometry on human samples (fig 4a) and in immunocytochemistry on human samples (fig 4g). Nat Genet (2017) ncbi
mouse monoclonal (3A6)
  • immunocytochemistry; human; 1:50; fig 1c
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, BioLegend ALCAM antibody (BioLegend, 343902) was used in immunocytochemistry on human samples at 1:50 (fig 1c). Nat Commun (2015) ncbi
mouse monoclonal (3A6)
  • immunocytochemistry; domestic sheep; fig 5
BioLegend ALCAM antibody (Biolegend, 3A6) was used in immunocytochemistry on domestic sheep samples (fig 5). J Tissue Eng Regen Med (2016) ncbi
Proteintech Group
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
Proteintech Group ALCAM antibody (Proteintech, 21972-1-AP) was used in western blot on human samples (fig 3a). Cell Death Dis (2019) ncbi
Cell Signaling Technology
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:400; fig 5
Cell Signaling Technology ALCAM antibody (Cell Signaling, TRA-1-81) was used in immunocytochemistry on human samples at 1:400 (fig 5). Nat Med (2016) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:800; tbl s1
In order to discuss how to use induced-pluripotent stem cells to generate neuron-like cells, Cell Signaling Technology ALCAM antibody (Cell Signaling, 4745) was used in immunocytochemistry on human samples at 1:800 (tbl s1). J Chin Med Assoc (2015) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; pigs ; fig 1
Cell Signaling Technology ALCAM antibody (Cell Signaling, 4745P) was used in immunocytochemistry on pigs samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:200
Cell Signaling Technology ALCAM antibody (Cell Signaling, 4745) was used in immunocytochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:800
In order to study age-related macular degeneration pathogenesis using stem cells differentiation into retinal pigment epithelial cells using T cells, Cell Signaling Technology ALCAM antibody (Cell signaling, 4745) was used in immunocytochemistry on human samples at 1:800. Front Aging Neurosci (2014) ncbi
Stemcell Technologies
  • flow cytometry; human
  • immunocytochemistry; human; 1:300
Stemcell Technologies ALCAM antibody (STEMCELL Technologies, 01556) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1:300. Acta Naturae (2014) ncbi
BD Biosciences
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:15; loading ...; fig s5e
BD Biosciences ALCAM antibody (BD Bioscience, 560884) was used in flow cytometry on human samples at 1:15 (fig s5e). Cell Death Dis (2020) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; loading ...; fig s3c
BD Biosciences ALCAM antibody (BD Biosciences, 560380) was used in flow cytometry on human samples (fig s3c). Haematologica (2019) ncbi
mouse monoclonal (3A6)
  • immunocytochemistry; human; loading ...; fig s1a
BD Biosciences ALCAM antibody (BD Biosciences, 560903) was used in immunocytochemistry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig s1d
BD Biosciences ALCAM antibody (BD Biosciences, 560884) was used in flow cytometry on human samples (fig s1d). Cell Rep (2019) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; 1:100; fig 3a
BD Biosciences ALCAM antibody (BD, 559263) was used in flow cytometry on human samples at 1:100 (fig 3a). Sci Rep (2018) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig s4c
BD Biosciences ALCAM antibody (BD Pharmingen, 559263) was used in flow cytometry on human samples (fig s4c). Hum Mol Genet (2017) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; domestic goat; 1:500; fig 3A
BD Biosciences ALCAM antibody (BD, 560884) was used in immunocytochemistry on domestic goat samples at 1:500 (fig 3A). BMC Biotechnol (2017) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; domestic goat; 1:500; fig 3A
BD Biosciences ALCAM antibody (BD, 560072) was used in immunocytochemistry on domestic goat samples at 1:500 (fig 3A). BMC Biotechnol (2017) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig 1a
BD Biosciences ALCAM antibody (BD Biosciences, 560380) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2017) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; 1:50; loading ...; fig st2
In order to show low doses of acetaminophen disrupts the integrity of tight junction and cell-matrix adhesions, BD Biosciences ALCAM antibody (BD Biosciences, 559263) was used in flow cytometry on human samples at 1:50 (fig st2). Sci Rep (2017) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences ALCAM antibody (BD Pharmingen, 562711) was used in flow cytometry on human samples (fig 1a). Biol Open (2017) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences ALCAM antibody (BD Pharmingen, 3A6) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (3A6)
  • flow cytometry; domestic sheep; loading ...
In order to discuss methods to generate ovine mesenchymal stromal cells, BD Biosciences ALCAM antibody (BD Pharmingen, 3A6) was used in flow cytometry on domestic sheep samples . J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (TRA-1-81)
  • immunohistochemistry; human; 1:200; loading ...; fig 1h
In order to characterize CTL07-II cells, BD Biosciences ALCAM antibody (BD Pharmingen, 560072) was used in immunohistochemistry on human samples at 1:200 (fig 1h). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig 3
BD Biosciences ALCAM antibody (Becton Dickinson, 563188) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2016) ncbi
mouse monoclonal (TRA-1-81)
  • flow cytometry; human; 1:50; loading ...; fig 2c
  • immunohistochemistry; human; 1:10; loading ...; fig 2d
BD Biosciences ALCAM antibody (BD Biosciences, 560174) was used in flow cytometry on human samples at 1:50 (fig 2c) and in immunohistochemistry on human samples at 1:10 (fig 2d). Development (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig 5
BD Biosciences ALCAM antibody (BD Biosciences, 560193) was used in flow cytometry on human samples (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (TRA-1-81)
  • flow cytometry; human; fig 5
BD Biosciences ALCAM antibody (BD Biosciences, 560161) was used in flow cytometry on human samples (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig 2
In order to study the role of kif3a in dental mesenchymal stem and precursor cell differentiation, BD Biosciences ALCAM antibody (BD Biosciences, 559263) was used in flow cytometry on human samples (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (3A6)
  • immunohistochemistry; human; fig 4
In order to study the human corneal endothelial cell via a 3D map, BD Biosciences ALCAM antibody (BD, 559260) was used in immunohistochemistry on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (TRA-1-81)
  • flow cytometry; human; fig 1
BD Biosciences ALCAM antibody (Becton Dickinson, 560161) was used in flow cytometry on human samples (fig 1). Stem Cell Rev (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig 1
BD Biosciences ALCAM antibody (Becton Dickinson, 560193) was used in flow cytometry on human samples (fig 1). Stem Cell Rev (2016) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; loading ...
BD Biosciences ALCAM antibody (BD Bioscience, 559263) was used in flow cytometry on human samples . Mol Med Rep (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:50; fig s1
In order to study the recapitulation of the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity due to human induced pluripotent stem cell-derived cardiomyocytes, BD Biosciences ALCAM antibody (BD Biosciences, 560173) was used in flow cytometry on human samples at 1:50 (fig s1). Nat Med (2016) ncbi
mouse monoclonal (3A6)
  • other; human; 500 ug/ml; fig 1
BD Biosciences ALCAM antibody (Becton Dickinson, 559260) was used in other on human samples at 500 ug/ml (fig 1). J Extracell Vesicles (2016) ncbi
mouse monoclonal (3A6)
  • flow cytometry; domestic sheep; 1:5; fig 3
In order to define a set of monoclonal antibodies for the immunophenotypic characterization of ovine mesenchymal stem cells, BD Biosciences ALCAM antibody (BD Biosciences, 559263) was used in flow cytometry on domestic sheep samples at 1:5 (fig 3). Cytometry A (2016) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:100
BD Biosciences ALCAM antibody (BD, 560173) was used in immunocytochemistry on human samples at 1:100. Nature (2016) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; fig s1
BD Biosciences ALCAM antibody (BD Biosciences, 560161) was used in immunocytochemistry on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig s1
BD Biosciences ALCAM antibody (BD Biosciences, 560884) was used in flow cytometry on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences ALCAM antibody (BD, 559263) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (TRA-1-81)
  • flow cytometry; human; 1:10; fig 1
BD Biosciences ALCAM antibody (BD, 560793) was used in flow cytometry on human samples at 1:10 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:10; fig 1
BD Biosciences ALCAM antibody (BD, 560380) was used in flow cytometry on human samples at 1:10 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; mouse; loading ...; fig 5a
In order to evaluate the 3D3 PODXL antibody for the elimination of tumorigenic pluripotent cells, BD Biosciences ALCAM antibody (BD Pharmingen, 560193) was used in flow cytometry on mouse samples (fig 5a). Stem Cells Dev (2016) ncbi
mouse monoclonal (KS1/4)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences ALCAM antibody (BD, KS1/4) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; tbl 2
BD Biosciences ALCAM antibody (BD Bioscience, 560885) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; domestic sheep; 20 ug/ml; fig 3
BD Biosciences ALCAM antibody (BD PharMigen, 559263) was used in flow cytometry on domestic sheep samples at 20 ug/ml (fig 3). Cell Tissue Bank (2016) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig 2
BD Biosciences ALCAM antibody (BD Biosciences, 559263) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig 2
BD Biosciences ALCAM antibody (BD Bioscience, 562711) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig s4
BD Biosciences ALCAM antibody (BD Pharmingen, 559263) was used in flow cytometry on human samples (fig s4). Stem Cell Reports (2015) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; fig 3
BD Biosciences ALCAM antibody (BD Biosciences, 560380) was used in flow cytometry on human samples (fig 3). Stem Cell Rev (2015) ncbi
mouse monoclonal (3A6)
  • immunocytochemistry; human
In order to generate patient-derived iPSCs from a Li-Fraumeni syndrome family and assess the role of mutant p53 in the development of osteosarcoma, BD Biosciences ALCAM antibody (BD Biosciences, 559263) was used in immunocytochemistry on human samples . Cell (2015) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human
In order to generate patient-derived iPSCs from a Li-Fraumeni syndrome family and assess the role of mutant p53 in the development of osteosarcoma, BD Biosciences ALCAM antibody (BD Biosciences, 560194) was used in immunocytochemistry on human samples . Cell (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; fig 5
BD Biosciences ALCAM antibody (BD Biosciences, 559263) was used in flow cytometry on human samples (fig 5). Stem Cell Reports (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; domestic sheep
BD Biosciences ALCAM antibody (BD Pharmingen, 3A6) was used in flow cytometry on domestic sheep samples . Cytotechnology (2016) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:500
BD Biosciences ALCAM antibody (BD biosciences, 560793) was used in immunocytochemistry on human samples at 1:500. Peerj (2014) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; loading ...; fig s3a
In order to describe methods to efficiently 'knock-in' multi-kilobase genes in human induced pluripotent stem cells, BD Biosciences ALCAM antibody (BD Biosciences, TRA-1-60) was used in flow cytometry on human samples (fig s3a). Nucleic Acids Res (2015) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; 1:500
BD Biosciences ALCAM antibody (BD Bioscience, 559263) was used in flow cytometry on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, BD Biosciences ALCAM antibody (Becton Dickinson, clone 3A6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:50
In order to use a multiplex high-throughput gene expression assay to detect endogenous expression of multiple developmental, functional, and disease markers in iPS cell-derived retinal pigment epithelium, BD Biosciences ALCAM antibody (BD Biosciences, 560173) was used in immunocytochemistry on human samples at 1:50. Stem Cells Transl Med (2014) ncbi
mouse monoclonal (3A6)
  • flow cytometry; human; 1 ug/1x106 cells
BD Biosciences ALCAM antibody (BD pharmingen, 559260) was used in flow cytometry on human samples at 1 ug/1x106 cells. J Cell Mol Med (2014) ncbi
Leica Biosystems
  • immunohistochemistry; human; 1:50; fig 1
Leica Biosystems ALCAM antibody (Novocastra, NCL-CD166) was used in immunohistochemistry on human samples at 1:50 (fig 1). Nat Commun (2016) ncbi
Articles Reviewed
  1. Marin Navarro A, Pronk R, van der Geest A, Oliynyk G, Nordgren A, Arsenian Henriksson M, et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 2020;11:52 pubmed publisher
  2. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  3. Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, et al. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica. 2019;: pubmed publisher
  4. Radhakrishnan S, Trentz O, Reddy M, Rela M, Kandasamy M, Sellathamby S. In vitro transdifferentiation of human adipose tissue-derived stem cells to neural lineage cells - a stage-specific incidence. Adipocyte. 2019;8:164-177 pubmed publisher
  5. Wu D, Zhang T, Liu Y, Deng S, Han R, Liu T, et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling. Cell Death Dis. 2019;10:349 pubmed publisher
  6. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed publisher
  7. Mair B, Tomic J, Masud S, Tonge P, Weiss A, Usaj M, et al. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Rep. 2019;27:599-615.e12 pubmed publisher
  8. Barros Silva J, Linn D, Steiner I, Guo G, Ali A, Pakula H, et al. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep. 2018;25:3504-3518.e6 pubmed publisher
  9. Chen Y, Qin X, An Q, Yi J, Feng F, Yin D, et al. Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes. EBioMedicine. 2018;32:31-42 pubmed publisher
  10. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  11. Paik E, O Neil A, Ng S, Sun C, Rubin L. Using intracellular markers to identify a novel set of surface markers for live cell purification from a heterogeneous hIPSC culture. Sci Rep. 2018;8:804 pubmed publisher
  12. Kumar B, Garcia M, Weng L, Jung X, Murakami J, Hu X, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2018;32:575-587 pubmed publisher
  13. Dominici C, Moreno Bravo J, Puiggros S, Rappeneau Q, Rama N, Vieugué P, et al. Floor-plate-derived netrin-1 is dispensable for commissural axon guidance. Nature. 2017;545:350-354 pubmed publisher
  14. Miller E, Kobayashi G, Musso C, Allen M, Ishiy F, de Caires L, et al. EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome. Hum Mol Genet. 2017;26:2177-2191 pubmed publisher
  15. Chen H, Zuo Q, Wang Y, Song J, Yang H, Zhang Y, et al. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters. BMC Biotechnol. 2017;17:11 pubmed publisher
  16. Fielding C, Weekes M, Nobre L, Růcková E, Wilkie G, Paulo J, et al. Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation. elife. 2017;6: pubmed publisher
  17. Flamier A, Singh S, Rasmussen T. A standardized human embryoid body platform for the detection and analysis of teratogens. PLoS ONE. 2017;12:e0171101 pubmed publisher
  18. Gamal W, Treskes P, Samuel K, Sullivan G, Siller R, Srsen V, et al. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep. 2017;7:37541 pubmed publisher
  19. Bharathan S, Manian K, Aalam S, Palani D, Deshpande P, Pratheesh M, et al. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biol Open. 2017;6:100-108 pubmed publisher
  20. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  21. Park R, Wang T, Koundakjian D, Hultquist J, Lamothe Molina P, Monel B, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017;49:193-203 pubmed publisher
  22. Bogachek M, Park J, De Andrade J, Lorenzen A, Kulak M, White J, et al. Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas. Stem Cell Reports. 2016;7:1140-1151 pubmed publisher
  23. Wu M, Tang W, Zhan X, Li Y, Peng Y, Huang X, et al. FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancer. Oncogenesis. 2016;5:e271 pubmed publisher
  24. Caminal M, Velez R, Rabanal R, Vivas D, Batlle Morera L, Aguirre M, et al. A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies. J Tissue Eng Regen Med. 2017;11:3408-3416 pubmed publisher
  25. Kele M, Day K, Rönnholm H, Schuster J, Dahl N, Falk A. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions. Stem Cell Res. 2016;17:474-478 pubmed publisher
  26. Hu X, García M, Weng L, Jung X, Murakami J, Kumar B, et al. Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche. Nat Commun. 2016;7:13095 pubmed publisher
  27. Muñoz López A, Romero Moya D, Prieto C, Ramos Mejia V, Agraz Doblas A, Varela I, et al. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency. Stem Cell Reports. 2016;7:602-618 pubmed publisher
  28. Zimmerlin L, Park T, Huo J, Verma K, Pather S, Talbot C, et al. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 2016;143:4368-4380 pubmed
  29. Ahmadian Baghbaderani B, Tian X, Scotty Cadet J, Shah K, Walde A, Tran H, et al. A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells. PLoS ONE. 2016;11:e0161229 pubmed publisher
  30. Ilmer M, Mazurek N, Byrd J, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7:e2337 pubmed publisher
  31. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed publisher
  32. Harfuddin Z, Dharmadhikari B, Wong S, Duan K, Poidinger M, Kwajah S, et al. Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. Sci Rep. 2016;6:29712 pubmed publisher
  33. He Z, Forest F, Gain P, Rageade D, Bernard A, Acquart S, et al. 3D map of the human corneal endothelial cell. Sci Rep. 2016;6:29047 pubmed publisher
  34. Zhang W, Chin T, Yang H, Nga M, Lunny D, Lim E, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702 pubmed publisher
  35. Baghbaderani B, Syama A, Sivapatham R, Pei Y, Mukherjee O, Fellner T, et al. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications. Stem Cell Rev. 2016;12:394-420 pubmed publisher
  36. Wang X, Zhu Y, Xu B, Wang J, Liu X. Identification of TLR2 and TLR4?induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals. Mol Med Rep. 2016;13:4969-80 pubmed publisher
  37. Burridge P, Li Y, Matsa E, Wu H, Ong S, Sharma A, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016;22:547-56 pubmed publisher
  38. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  39. Khan M, Chandrashekran A, Smith R, Dudhia J. Immunophenotypic characterization of ovine mesenchymal stem cells. Cytometry A. 2016;89:443-50 pubmed publisher
  40. Francis K, Ton A, Xin Y, O Halloran P, Wassif C, Malik N, et al. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes. Nat Med. 2016;22:388-96 pubmed publisher
  41. Sagi I, Chia G, Golan Lev T, Peretz M, Weissbein U, Sui L, et al. Derivation and differentiation of haploid human embryonic stem cells. Nature. 2016;532:107-11 pubmed publisher
  42. Zou L, Chen Q, Quanbeck Z, Bechtold J, Kaufman D. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016;6:22868 pubmed publisher
  43. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  44. Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed publisher
  45. Kang L, Yao C, Khodadadi Jamayran A, Xu W, Zhang R, Banerjee N, et al. The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells. Stem Cells Dev. 2016;25:556-68 pubmed publisher
  46. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  47. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  48. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  49. Asanoma K, Liu G, Yamane T, Miyanari Y, Takao T, Yagi H, et al. Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells. Mol Cell Biol. 2015;35:4096-109 pubmed publisher
  50. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  51. Landa Solís C, Granados Montiel J, Olivos Meza A, Ortega Sánchez C, Cruz Lemini M, Hernández Flores C, et al. Cryopreserved CD90+ cells obtained from mobilized peripheral blood in sheep: a new source of mesenchymal stem cells for preclinical applications. Cell Tissue Bank. 2016;17:137-45 pubmed publisher
  52. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed publisher
  53. Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
  54. Takenaka C, Miyajima H, Yoda Y, Imazato H, Yamamoto T, Gomi S, et al. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE. 2015;10:e0129855 pubmed publisher
  55. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed publisher
  56. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed publisher
  57. Tang X, Chen X, Xu Y, Qiao Y, Zhang X, Wang Y, et al. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells. Cell Signal. 2015;27:1694-702 pubmed publisher
  58. Zhou H, Martínez H, Sun B, Li A, Zimmer M, Katsanis N, et al. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. Stem Cell Rev. 2015;11:652-65 pubmed publisher
  59. Zhang W, Pei Y, Zhong L, Wen B, Cao S, Han J. Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions. PLoS ONE. 2015;10:e0124562 pubmed publisher
  60. Zhang P, Yang X, Ma X, Ingram D, Lazar A, Torres K, et al. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Mol Cancer. 2015;14:55 pubmed publisher
  61. Lee D, Su J, Kim H, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240-54 pubmed publisher
  62. Ali H, Al Yatama M, Abu Farha M, Behbehani K, Al Madhoun A. Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS ONE. 2015;10:e0122465 pubmed publisher
  63. Narcisi R, Cleary M, Brama P, Hoogduijn M, Tüysüz N, ten Berge D, et al. Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation. Stem Cell Reports. 2015;4:459-72 pubmed publisher
  64. Caminal M, Peris D, Fonseca C, Barrachina J, Codina D, Rabanal R, et al. Cartilage resurfacing potential of PLGA scaffolds loaded with autologous cells from cartilage, fat, and bone marrow in an ovine model of osteochondral focal defect. Cytotechnology. 2016;68:907-19 pubmed publisher
  65. Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, et al. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog. 2015;54:1710-21 pubmed publisher
  66. Johnstone S, Liley M, Dalby M, Barnett S. Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces. Acta Biomater. 2015;13:266-76 pubmed publisher
  67. Wilson P, Payne T. Genetic reprogramming of human amniotic cells with episomal vectors: neural rosettes as sentinels in candidate selection for validation assays. Peerj. 2014;2:e668 pubmed publisher
  68. Byrne S, Ortiz L, Mali P, Aach J, Church G. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 2015;43:e21 pubmed publisher
  69. Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M, et al. Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture. PLoS ONE. 2014;9:e112900 pubmed publisher
  70. Sako Kubota K, Tanaka N, Nagae S, Meng W, Takeichi M. Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions. Mol Biol Cell. 2014;25:3851-60 pubmed publisher
  71. Tsai H, Deng W, Lai W, Chiu W, Yang C, Tsai Y, et al. Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. PLoS ONE. 2014;9:e104937 pubmed publisher
  72. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  73. Chang Y, Chang W, Hung K, Yang D, Cheng Y, Liao Y, et al. The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Front Aging Neurosci. 2014;6:191 pubmed publisher
  74. Ma L, Pan Q, Sun F, Yu Y, Wang J. Cluster of differentiation 166 (CD166) regulates cluster of differentiation (CD44) via NF-?B in liver cancer cell line Bel-7402. Biochem Biophys Res Commun. 2014;451:334-8 pubmed publisher
  75. Ferrer M, Corneo B, Davis J, Wan Q, Miyagishima K, King R, et al. A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epithelium. Stem Cells Transl Med. 2014;3:911-22 pubmed publisher
  76. Muchkaeva I, Dashinimaev E, Artyuhov A, Myagkova E, Vorotelyak E, Yegorov Y, et al. Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells. Acta Naturae. 2014;6:45-53 pubmed
  77. Zhou J, Lu P, Ren H, Zheng Z, Ji J, Liu H, et al. 17?-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury. J Cell Mol Med. 2014;18:326-43 pubmed publisher
  78. Weber B, Kehl D, Bleul U, Behr L, Sammut S, Frese L, et al. In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med. 2016;10:52-70 pubmed publisher
  79. Lv X, Zhou G, Liu Y, Liu X, Chen J, Luo X, et al. In vitro proliferation and differentiation of adipose-derived stem cells isolated using anti-CD105 magnetic beads. Int J Mol Med. 2012;30:826-34 pubmed publisher